Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study for Patients Who Completed GENA-05 (NuProtect)
2013-003997-28Phase 3Completed
- Sponsor
- Octapharma
- Start
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Octapharma. Primary endpoint: Immunogenicity of Human-cl rhFVIII. Started Nov 2013; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2013-003997-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003997-28.